In contrast, when the function of mitophagy is disrupted, phosphorylated p53 cannot be eliminated by mitophagy and is delivered to the nucleus, where it binds to the NANOG promoter and suppresses the production of NANOG, leading to a decrease in hepatic cancer stemness (55). This evidence concerns the gene NANOG and liver cancer.